{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T21:08:04Z","timestamp":1794258484817,"version":"4.9.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T00:00:00Z","timestamp":1636070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T00:00:00Z","timestamp":1636070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004085","name":"ministry of education, science and technology","doi-asserted-by":"publisher","award":["2016M3C7A1914123"],"award-info":[{"award-number":["2016M3C7A1914123"]}],"id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Neurodegener"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Focused ultrasound (FUS)-mediated blood\u2013brain barrier (BBB) opening has shown efficacy in removal of amyloid plaque and improvement of cognitive functions in preclinical studies, but this is rarely reported in clinical studies. This study was conducted to evaluate the safety, feasibility and potential benefits of repeated extensive BBB opening.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In this open-label, prospective study, six patients with Alzheimer\u2019s disease (AD) were enrolled at Severance Hospital in Korea between August 2020 and September 2020. Five of them completed the study. FUS-mediated BBB opening, targeting the bilateral frontal lobe regions over 20 cm\n                      <jats:sup>3<\/jats:sup>\n                      , was performed twice at three-month intervals. Magnetic resonance imaging,\n                      <jats:sup>18<\/jats:sup>\n                      F-Florbetaben (FBB) positron emission tomography, Caregiver-Administered Neuropsychiatric Inventory (CGA-NPI) and comprehensive neuropsychological tests were performed before and after the procedures.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      FUS targeted a mean volume of 21.1\u2009\u00b1\u20092.7 cm\n                      <jats:sup>3<\/jats:sup>\n                      and BBB opening was confirmed at 95.7%\u2009\u00b1\u20099.4% of the targeted volume. The frontal-to-other cortical region FBB standardized uptake value ratio at 3\u00a0months after the procedure showed a slight decrease, which was statistically significant, compared to the pre-procedure value (\u2212\u20091.6%, 0.986\n                      <jats:italic>vs<\/jats:italic>\n                      1.002,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.043). The CGA-NPI score at 2\u00a0weeks after the second procedure significantly decreased compared to baseline (2.2\u2009\u00b1\u20093.0\n                      <jats:italic>vs<\/jats:italic>\n                      8.6\u2009\u00b1\u20096.0,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.042), but recovered after 3\u00a0months (5.2\u2009\u00b1\u20095.8\n                      <jats:italic>vs<\/jats:italic>\n                      8.6\u2009\u00b1\u20096.0,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.89). No adverse effects were observed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The repeated and extensive BBB opening in the frontal lobe is safe and feasible for patients with AD. In addition, the BBB opening is potentially beneficial for amyloid removal in AD patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40035-021-00269-8","type":"journal-article","created":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T07:03:52Z","timestamp":1636095832000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":89,"title":["Extensive frontal focused ultrasound mediated blood\u2013brain barrier opening for the treatment of Alzheimer\u2019s disease: a proof-of-concept study"],"prefix":"10.1186","volume":"10","author":[{"given":"So Hee","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoungwon","family":"Baik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seun","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Seok","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byoung Seok","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2717-0101","authenticated-orcid":false,"given":"Jin Woo","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,5]]},"reference":[{"issue":"1","key":"269_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00401-009-0532-1","volume":"118","author":"C Duyckaerts","year":"2009","unstructured":"Duyckaerts C, Delatour B, Potier M-C. Classification and basic pathology of Alzheimer disease. Acta Neuropathol. 2009;118(1):5\u201336.","journal-title":"Acta Neuropathol"},{"issue":"5580","key":"269_CR2","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science. 2002;297(5580):353\u20136.","journal-title":"Science"},{"key":"269_CR3","doi-asserted-by":"crossref","unstructured":"Aisen P, Cummings J, Doody R, Kramer L, Salloway S, Selkoe D, et al. The future of anti-amyloid trials. J Prev Alzheimers Dis. 2020:1\u20136.","DOI":"10.14283\/jpad.2020.24"},{"key":"269_CR4","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3389\/fphar.2019.00086","volume":"10","author":"KT Chen","year":"2019","unstructured":"Chen KT, Wei KC, Liu HL. Theranostic strategy of focused ultrasound induced blood\u2013brain barrier opening for CNS disease treatment. Front Pharmacol. 2019;10:86.","journal-title":"Front Pharmacol"},{"issue":"3","key":"269_CR5","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1148\/radiol.14140245","volume":"273","author":"A Burgess","year":"2014","unstructured":"Burgess A, Dubey S, Yeung S, Hough O, Eterman N, Aubert I, et al. Alzheimer disease in a mouse model: MR imaging-guided focused ultrasound targeted to the hippocampus opens the blood\u2013brain barrier and improves pathologic abnormalities and behavior. Radiology. 2014;273(3):736\u201345.","journal-title":"Radiology"},{"issue":"1","key":"269_CR6","doi-asserted-by":"publisher","first-page":"12882","DOI":"10.1038\/s41598-018-31071-8","volume":"8","author":"PH Hsu","year":"2018","unstructured":"Hsu PH, Lin YT, Chung YH, Lin KJ, Yang LY, Yen TC, et al. Focused ultrasound-induced blood\u2013brain barrier opening enhances GSK-3 inhibitor delivery for amyloid-beta plaque reduction. Sci Rep. 2018;8(1):12882.","journal-title":"Sci Rep"},{"issue":"18","key":"269_CR7","doi-asserted-by":"publisher","first-page":"5396","DOI":"10.7150\/thno.28717","volume":"9","author":"ME Karakatsani","year":"2019","unstructured":"Karakatsani ME, Kugelman T, Ji R, Murillo M, Wang S, Niimi Y, et al. Unilateral focused ultrasound-induced blood\u2013brain barrier opening reduces phosphorylated Tau from the rTg4510 mouse model. Theranostics. 2019;9(18):5396\u2013411.","journal-title":"Theranostics"},{"issue":"1","key":"269_CR8","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13195-019-0569-x","volume":"11","author":"J Shin","year":"2019","unstructured":"Shin J, Kong C, Lee J, Choi BY, Sim J, Koh CS, et al. Focused ultrasound-induced blood\u2013brain barrier opening improves adult hippocampal neurogenesis and cognitive function in a cholinergic degeneration dementia rat model. Alzheimers Res Ther. 2019;11(1):110.","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"269_CR9","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1038\/s41467-018-04529-6","volume":"9","author":"N Lipsman","year":"2018","unstructured":"Lipsman N, Meng Y, Bethune AJ, Huang Y, Lam B, Masellis M, et al. Blood\u2013brain barrier opening in Alzheimer\u2019s disease using MR-guided focused ultrasound. Nat Commun. 2018;9(1):2336.","journal-title":"Nat Commun"},{"issue":"17","key":"269_CR10","doi-asserted-by":"publisher","first-page":"9180","DOI":"10.1073\/pnas.2002571117","volume":"117","author":"AR Rezai","year":"2020","unstructured":"Rezai AR, Ranjan M, D\u2019Haese PF, Haut MW, Carpenter J, Najib U, et al. Noninvasive hippocampal blood\u2013brain barrier opening in Alzheimer\u2019s disease with focused ultrasound. Proc Natl Acad Sci U S A. 2020;117(17):9180\u20132.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"269_CR11","doi-asserted-by":"crossref","unstructured":"D'Haese PF, Ranjan M, Song A, Haut MW, Carpenter J, Dieb G, et al. Beta-amyloid plaque reduction in the hippocampus after focused ultrasound-induced blood\u2013brain barrier opening in Alzheimer's disease. Front Hum Neurosci. 2020;14:593672.","DOI":"10.3389\/fnhum.2020.593672"},{"issue":"3","key":"269_CR12","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7(3):263\u20139.","journal-title":"Alzheimers Dement"},{"issue":"7","key":"269_CR13","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1093\/brain\/aws125","volume":"135","author":"N Villain","year":"2012","unstructured":"Villain N, Ch\u00e9telat G, Grassiot B, Bourgeat P, Jones G, Ellis KA, et al. Regional dynamics of amyloid-\u03b2 deposition in healthy elderly, mild cognitive impairment and Alzheimer\u2019s disease: a voxelwise PiB\u2013PET longitudinal study. Brain. 2012;135(7):2126\u201339.","journal-title":"Brain"},{"key":"269_CR14","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.neuroimage.2014.08.037","volume":"102","author":"T Funck","year":"2014","unstructured":"Funck T, Paquette C, Evans A, Thiel A. Surface-based partial-volume correction for high-resolution PET. Neuroimage. 2014;102:674\u201387.","journal-title":"Neuroimage"},{"issue":"8","key":"269_CR15","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.jalz.2015.02.004","volume":"11","author":"O Sabri","year":"2015","unstructured":"Sabri O, Sabbagh MN, Seibyl J, Barthel H, Akatsu H, Ouchi Y, et al. Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer\u2019s disease: phase 3 study. Alzheimers Dement. 2015;11(8):964\u201374.","journal-title":"Alzheimers Dement"},{"key":"269_CR16","volume-title":"Seoul neuropsychological screening battery","author":"Y Kang","year":"2003","unstructured":"Kang Y, Na D, Hahn S. Seoul neuropsychological screening battery. Incheon: Human Brain Research & Consulting Co.; 2003."},{"issue":"1","key":"269_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.12779\/dnd.2018.17.1.11","volume":"17","author":"J Chin","year":"2018","unstructured":"Chin J, Park J, Yang SJ, Yeom J, Ahn Y, Baek MJ, et al. Re-standardization of the Korean-Instrumental Activities of Daily Living (K-IADL): clinical usefulness for various neurodegenerative diseases. Dement Neurocogn Disord. 2018;17(1):11\u201322.","journal-title":"Dement Neurocogn Disord"},{"issue":"1","key":"269_CR18","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1177\/089198873258818","volume":"17","author":"SJ Kang","year":"2004","unstructured":"Kang SJ, Choi SH, Lee BH, Jeong Y, Hahm DS, Han IW, et al. Caregiver-administered neuropsychiatric inventory (CGA-NPI). J Geriatr Psychiatry Neurol. 2004;17(1):32\u20135.","journal-title":"J Geriatr Psychiatry Neurol."},{"issue":"1","key":"269_CR20","doi-asserted-by":"publisher","first-page":"4373","DOI":"10.1038\/s41467-019-12426-9","volume":"10","author":"A Abrahao","year":"2019","unstructured":"Abrahao A, Meng Y, Llinas M, Huang Y, Hamani C, Mainprize T, et al. First-in-human trial of blood\u2013brain barrier opening in amyotrophic lateral sclerosis using MR-guided focused ultrasound. Nat Commun. 2019;10(1):4373.","journal-title":"Nat Commun"},{"key":"269_CR21","unstructured":"Park SH, Kim MJ, Jung HH, Chang WS, Choi HS, Rachmilevitch I, et al. Safety and feasibility of multiple blood-brain barrier disruptions for the treatment of glioblastoma in patients undergoing standard adjuvant chemotherapy. J Neurosurg. 2020:1\u20139."},{"issue":"6","key":"269_CR22","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1212\/WNL.0000000000008924","volume":"94","author":"R Waziry","year":"2020","unstructured":"Waziry R, Chibnik LB, Bos D, Ikram MK, Hofman A. Risk of hemorrhagic and ischemic stroke in patients with Alzheimer disease: a synthesis of the literature. Neurology. 2020;94(6):265\u201372.","journal-title":"Neurology"},{"issue":"5","key":"269_CR23","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/BF00294173","volume":"87","author":"L Buee","year":"1994","unstructured":"Buee L, Hof PR, Bouras C, Delacourte A, Perl DP, Morrison JH, et al. Pathological alterations of the cerebral microvasculature in Alzheimer\u2019s disease and related dementing disorders. Acta Neuropathol. 1994;87(5):469\u201380.","journal-title":"Acta Neuropathol"},{"key":"269_CR24","doi-asserted-by":"crossref","unstructured":"Leinenga G, Gotz J. Scanning ultrasound removes amyloid-beta and restores memory in an Alzheimer's disease mouse model. Sci Transl Med. 2015;7(278):278ra33.","DOI":"10.1126\/scitranslmed.aaa2512"},{"issue":"4","key":"269_CR25","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s00228-018-02620-x","volume":"75","author":"N Zhang","year":"2019","unstructured":"Zhang N, Lv Y, Li H, Chen J, Li Y, Yin F, et al. Quantifying placebo responses in clinical evaluation of neuropsychiatric symptoms in Alzheimer\u2019s disease. Eur J Clin Pharmacol. 2019;75(4):497\u2013509.","journal-title":"Eur J Clin Pharmacol"},{"issue":"10","key":"269_CR26","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1111\/ene.13076","volume":"23","author":"N Boublay","year":"2016","unstructured":"Boublay N, Schott AM, Krolak-Salmon P. Neuroimaging correlates of neuropsychiatric symptoms in Alzheimer\u2019s disease: a review of 20 years of research. Eur J Neurol. 2016;23(10):1500\u20139.","journal-title":"Eur J Neurol"},{"issue":"7618","key":"269_CR27","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature19323","volume":"537","author":"J Sevigny","year":"2016","unstructured":"Sevigny J, Chiao P, Bussiere T, Weinreb PH, Williams L, Maier M, et al. The antibody aducanumab reduces Abeta plaques in Alzheimer\u2019s disease. Nature. 2016;537(7618):50\u20136.","journal-title":"Nature"},{"key":"269_CR28","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.jconrel.2020.05.040","volume":"324","author":"N Todd","year":"2020","unstructured":"Todd N, Angolano C, Ferran C, Devor A, Borsook D, McDannold N. Secondary effects on brain physiology caused by focused ultrasound-mediated disruption of the blood\u2013brain barrier. J Control Release. 2020;324:450\u20139.","journal-title":"J Control Release"},{"key":"269_CR29","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.expneurol.2013.05.008","volume":"248","author":"JF Jord\u00e3o","year":"2013","unstructured":"Jord\u00e3o JF, Th\u00e9venot E, Markham-Coultes K, Scarcelli T, Weng YQ, Xhima K, et al. Amyloid-\u03b2 plaque reduction, endogenous antibody delivery and glial activation by brain-targeted, transcranial focused ultrasound. Exp Neurol. 2013;248:16\u201329.","journal-title":"Exp Neurol"},{"issue":"6","key":"269_CR30","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1002\/ana.25604","volume":"86","author":"Y Meng","year":"2019","unstructured":"Meng Y, Abrahao A, Heyn CC, Bethune AJ, Huang Y, Pople CB, et al. Glymphatics visualization after focused ultrasound-induced blood\u2013brain barrier opening in humans. Ann Neurol. 2019;86(6):975\u201380.","journal-title":"Ann Neurol"},{"key":"269_CR31","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.neuroimage.2019.06.060","volume":"200","author":"Y Meng","year":"2019","unstructured":"Meng Y, MacIntosh BJ, Shirzadi Z, Kiss A, Bethune A, Heyn C, et al. Resting state functional connectivity changes after MR-guided focused ultrasound mediated blood\u2013brain barrier opening in patients with Alzheimer\u2019s disease. Neuroimage. 2019;200:275\u201380.","journal-title":"Neuroimage"},{"issue":"7","key":"269_CR32","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.ultrasmedbio.2007.12.015","volume":"34","author":"N Sheikov","year":"2008","unstructured":"Sheikov N, McDannold N, Sharma S, Hynynen K. Effect of focused ultrasound applied with an ultrasound contrast agent on the tight junctional integrity of the brain microvascular endothelium. Ultrasound Med Biol. 2008;34(7):1093\u2013104.","journal-title":"Ultrasound Med Biol"},{"issue":"11","key":"269_CR33","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1002\/jum.14256","volume":"36","author":"T Alecou","year":"2017","unstructured":"Alecou T, Giannakou M, Damianou C. Amyloid beta plaque reduction with antibodies crossing the blood\u2013brain barrier, which was opened in 3 sessions of focused ultrasound in a rabbit model. J Ultrasound Med. 2017;36(11):2257\u201370.","journal-title":"J Ultrasound Med"},{"key":"269_CR34","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.expneurol.2013.05.008","volume":"248","author":"JF Jordao","year":"2013","unstructured":"Jordao JF, Thevenot E, Markham-Coultes K, Scarcelli T, Weng YQ, Xhima K, et al. Amyloid-beta plaque reduction, endogenous antibody delivery and glial activation by brain-targeted, transcranial focused ultrasound. Exp Neurol. 2013;248:16\u201329.","journal-title":"Exp Neurol"},{"issue":"1","key":"269_CR35","doi-asserted-by":"publisher","first-page":"14061","DOI":"10.1038\/s41598-018-32250-3","volume":"8","author":"CT Poon","year":"2018","unstructured":"Poon CT, Shah K, Lin C, Tse R, Kim KK, Mooney S, et al. Time course of focused ultrasound effects on beta-amyloid plaque pathology in the TgCRND8 mouse model of Alzheimer\u2019s disease. Sci Rep. 2018;8(1):14061.","journal-title":"Sci Rep"},{"key":"269_CR36","doi-asserted-by":"crossref","unstructured":"Pardridge WM. Treatment of Alzheimer's disease and blood\u2013brain barrier drug delivery. Pharmaceuticals (Basel). 2020;13(11).","DOI":"10.3390\/ph13110394"}],"container-title":["Translational Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-021-00269-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40035-021-00269-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-021-00269-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T07:06:36Z","timestamp":1636095996000},"score":1,"resource":{"primary":{"URL":"https:\/\/translationalneurodegeneration.biomedcentral.com\/articles\/10.1186\/s40035-021-00269-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,5]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["269"],"URL":"https:\/\/doi.org\/10.1186\/s40035-021-00269-8","relation":{},"ISSN":["2047-9158"],"issn-type":[{"value":"2047-9158","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,5]]},"assertion":[{"value":"20 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Study approval by Institutional Review Board of Severance Hospital was obtained before the study initiation (No. 1-2019-0095). Written informed consent was obtained from all participants and their primary caregivers.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethic approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"44"}}